Marshall Wace North America’s Ovid Therapeutics OVID Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-12,735	Closed	-$41K	–	1514
2019 Q3	$41K	Buy	+12,735	New	+$41K	﹤0.01%	1183